Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INDAPAMIDE vs INFLIXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

INDAPAMIDE vs INFLIXIMAB: Safety Overview

Metric INDAPAMIDE INFLIXIMAB
Total FAERS Reports 4,876 140,189
Deaths Reported 256 7,516
Death Rate 5.3% 5.4%
Hospitalizations 2,945 36,324
Average Patient Age 68.9 yrs 43.9 yrs
% Female Patients 58.1% 64.4%
FDA Approval Date Apr 29, 1993 N/A
Manufacturer Direct_Rx Organon LLC
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription